BioMed Research International / 2014 / Article / Tab 4

Research Article

Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer

Table 4

Summary of pathways returned by REACTOME using DAVID for early- and late-stage NSCLC.

Early-stage NSCLC
TermCount% value

Hemostasis627.3
Signaling in immune system627.3
Integrin cell surface interactions313.60.0223
Metabolism of carbohydrates313.60.0295

Late-stage NSCLC
TermCount% value

Cell cycle, mitotic2134.4
Cell cycle checkpoints1016.4
Cdc20: phospho-APC/C-mediated degradation of cyclin A69.8
APC-Cdc20-mediated degradation of Nek2A46.60.00211
DNA replication58.20.0239